Skip to main content
Summary
Profile
Financials
Events
Ownership
Options

Company Info

Industry Chemicals: Major Diversified
Sector Process Industries
Employees 9,220
CEO Mr. Albert Yuan Chao
Address 2801 Post Oak Boulevard Suite 600, Houston, TX 77056-6136
Phone 1.713.960.9111
Website www.westlake.com

Westlake Chemical Corp. manufactures and markets petrochemicals, polymers and fabricated building products. It operates through the following segments: Olefins and Vinyls. The Olefins segment manufactures ethylene, polyethylene and styrene and associated co-products at the manufacturing facility in Lake Charles and polyethylene at the Longview facility. The Vinyls segment manufactures and sells building products fabricated from polyvinyl chloride, including pipe, fittings, profiles, foundation, building products, fence and deck components, window and door components, film and sheet products. The company was founded by Ting Tsung Chao in 1986 and is headquartered in Houston, TX.

Competitors

Company Name 3 Month
%Change
1 Year
%Change
Westlake Chemical Corp. 15.09% 27.44%
Linde Plc 2.97% 26.54%
The Sherwin-Williams Co. 6.96% 32.64%
Ecolab, Inc. 1.44% 3.76%
Air Products & Chemicals, Inc. 9.40% 5.58%

Statement Summary

as of 4:10 ET PM 11/24/2021
Total Assets (MRQ) 17.1 B
Total Liabilities (MRQ) 9.2 B
Shareholders’ Equity (MRQ) 7.9 B
Total Revenue (Annual) 3.1 B
Net Income (Annual) 604.0 M

Earnings And Estimates

as of 4:10 ET PM 11/24/2021

Current Qtr EPS Estimate 4.33
Current FY EPS Estimate 14.75
Long Term EPS Growth Estimate 59.10
Next Expected Earnings Date //

WLK vs S&P 500

as of 11/24/2021
Relative To
S&P 500
WLK
4 Weeks n/a n/a
12 Weeks n/a n/a
YTD n/a n/a

Earnings Surprises

as of 4:10 ET PM 11/24/2021
Fiscal Quarter Estimate Actual Surprise
09/2021 3.96 4.69 +18.50%
06/2021 3.52 4.04 +14.68%
03/2021 1.54 1.87 +21.05%
12/2020 0.74 0.87 +17.17%
09/2020 0.47 0.45 -3.78%
06/2020 0.00 0.11 -8,111.65%
03/2020 0.57 0.65 +13.43%
12/2019 0.86 0.59 -31.57%

Financial Strength

as of 4:10 ET PM 11/24/2021
Pre-Tax Margin 26.61
Net Margin 558.34
Operating Margin 28.38
Return On Equity 22.31
Return On Assets 9.60
Inventory Turnover (TTM) 7.81
Sales Growth (MRQ) 10.95

Ratios

as of 4:10 PM ET 11/24/2021
Price/Earnings (TTM) 8.65
Price/Book (MRQ) 1.74
Price/Cash Flow (TTM) 6.17
Book Value (MRQ) 57.10
Quick Ratio (MRQ) 2.80
Current Ratio (MRQ) 3.39
Total Debt/Equity (MRQ) 0.77

Short Interest

as of 1:10 PM ET 11/26/2021
% Short - 2.25%
% Remaining Float - 97.75%
Current Last Month
Short Interest Date 11/15/2021 10/29/2021
Short Interest Shares 746,071 1,424,825
Short Interest Ratio 1.1 2.8
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items
0,0.00 0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations
0,0.00 0,0.00
Cash from
Activities
0,0.00 0,0.00
Cash from
Fin. Activities
0,0.00 0,0.00

TOTAL ASSETS

TOTAL LIABILITIES

TOTAL EQUITY

Balance Sheet

M Y
ASSETS
Cash And Equivalents 0,0.00
Receivables 0,0.00
Inventories 0,0.00
Other Current Assets 0,0.00
Total Current Assets 0,0.00
Property, Plant & Equipment, Gross 0,0.00
Accumulated Depreciation & Depletion 0,0.00
Property, Plant & Equipment, Net 0,0.00
Intangibles 0,0.00
Other Non-Current Assets 0,0.00
Total Non-Current Assets 0,0.00
TOTAL ASSETS 0,0.00
Liabilities & Shareholder Equity
Accounts Payable 0,0.00
Short Term Debt 0,0.00
Total Current Liabilities 0,0.00
Long Term Debt 0,0.00
Deferred Income Taxes 0,0.00
Other Non-Current Liabilities 0,0.00
Minority Interest 0,0.00
Total Non-Current Liabilities 0,0.00
Preferred Stock Equity 0,0.00
Common Stock Equity 0,0.00
Common Par 0,0.00
Additional Paid In Capital 0,0.00
Cumulative Translation Adjustment 0,0.00
Retained Earnings 0,0.00
Treasury Stock 0,0.00
Other Equity Adjustments 0,0.00
Total Capitalization 0,0.00
TOTAL EQUITY 0,0.00
TOTAL LIABILITIES & STOCK EQUITY 0,0.00
Total Common Shares Outstanding 0,0.00
Preferred Shares 0,0.00
Treasury Shares 0,0.00
Basic Weighted Shares Outstanding 0,0.00
Diluted Weighted Shares Outstanding 0,0.00
Number Of Employees 0,0.00
Number Of Part-Time Employees 0,0.00

TOTAL REVENUES

EBT Excluding Unusual Items

NET INCOME

Income Statement

M Y
Sales 0,0.00
Cost Of Sales 0,0.00
Gross Operating Profit 0,0.00
Selling, General, And Administrative Expenses 0,0.00
Research & Development 0,0.00
Operating Income Before D & A (EBITDA) 0,0.00
Depreciation & Amortization 0,0.00
Interest Income 0,0.00
Other Income - Net 0,0.00
Special Income / Charges 0,0.00
Total Income Before Interest Expenses (EBIT) 0,0.00
Interest Expense 0,0.00
Pre-Tax Income 0,0.00
Income Taxes 0,0.00
Minority Interest 0,0.00
Net Income From Continuing Operations 0,0.00
Net Income From Discontinued Operations 0,0.00
Net Income From Total Operations 0,0.00
Extraordinary Income/Losses 0,0.00
Income From Cum. Effect Of Acct. Change 0,0.00
Income From Tax Loss Carryforward 0,0.00
Other Gains / Losses 0,0.00
Total Net Income 0,0.00
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Preferred Dividends 0,0.00
Net Income Available To Common 0,0.00
Basic EPS From Continuing Ops. 0,0.00
Basic EPS From Discontinued Ops. 0,0.00
Basic EPS From Total Operations 0,0.00
Basic EPS From Extraordinary Inc. 0,0.00
Basic EPS From Cum Effect Of Accounting Change 0,0.00
Basic EPS From Tax Loss Carryf'd. 0,0.00
Basic EPS From Other Gains (Losses) 0,0.00
Basic EPS, Total 0,0.00
Basic Normalized Net Income/Share 0,0.00
EPS From Continuing Ops. 0,0.00
EPS From Discontinued Ops 0,0.00
EPS From Total Ops. 0,0.00
EPS From Extraord. Inc. 0,0.00
EPS From Cum Effect of Accounting Change 0,0.00
EPS From Tax Loss Carfd. 0,0.00
EPS From Other Gains (L) 0,0.00
EPS, Total 0,0.00
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Dividends Paid Per Share 0,0.00

CASH FROM OPERATIONS

CASH FROM INVESTING ACTIVITIES

CASH FROM FINANCING ACTIVITIES

Cash Flow Statement

M Y
Cash Flow From Operating Activities
Net Income (Loss) 0,0.00
Operating Gains/Losses 0,0.00
Gross Operating Profit 0,0.00
(Increase) Decrease In Receivables 0,0.00
(Increase) Decrease In Inventories 0,0.00
(Increase) Decrease In Other Current Assets 0,0.00
(Decrease) Increase In Other Current Liabilities 0,0.00
(Increase) Decrease In Other Working Capital 0,0.00
Other Non-Cash Items 0,0.00
Net Cash From Continuing Operations 0,0.00
Net Cash From Discontinued Operations 0,0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 0,0.00
Sale Of Property, Plant & Equipment 0,0.00
Cash Used For Investing Activities
Sale Of Short-Term Investments 0,0.00
Purchases Of Property, Plant & Equipment 0,0.00
Acquisitions 0,0.00
Purchases Of Short-Term Investments 0,0.00
Other Cash From Investing Activities 0,0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 0,0.00
Issuance Of Debt 0,0.00
Cash Used For Financing Activities
Issuance Of Capital Stock 0,0.00
Repayment Of Long-Term Debt 0,0.00
Repurchase Of Capital Stock 0,0.00
Payment Of Cash Dividends 0,0.00
Other Financing Charges, Net 0,0.00
Net Cash From Financing Activities 0,0.00
Effect Of Exchange Rate Changes 0,0.00
Net Change In Cash & Cash Equivalents 0,0.00

Earnings Estimates

as of 4:10 ET PM 11/24/2021
Current Qtr
(12/2021)
Next Qtr
(03/2022)
Consensus Estimate $4.33 $3.11
# of Estimates 16 10
High Estimate $5.72 $4.95
Low Estimate $2.89 $1.78
Year Ago EPS $0.88 $1.88
Year Over Year Growth Estimate 389.38% 65.26%
Current Yr
(12/2021)
Next Yr
(12/2022)
Consensus Estimate $14.75 $12.82
# of Estimates 17 17
High Estimate $16.46 $17.60
Low Estimate $12.95 $9.20
Year Ago EPS $2.56 $14.75
Year Over Year Growth Estimate 476.36% -13.10%
Current Qtr
(12/2021)
Next Qtr
(03/2022)
Current Year
(12/2021)
Next Year
(12/2022)
Consensus Estimate $4.33 $3.11 $14.75 $12.82
# of Estimates 16 10 17 17
High Estimate $5.72 $4.95 $16.46 $17.60
Low Estimate $2.89 $1.78 $12.95 $9.20
Year Ago EPS $0.88 $1.88 $2.56 $14.75
Year Over Year Growth Estimate 389.38% 65.26% 476.36% -13.10%

Insider Information Summary

as of 10/31/2021
% Insiders - 74.13%
% Remaining Total Shares - 25.87%
Current 1 Month
Net Insider Transaction 24.60 K 24.60 K
Shares Bought 24.60 K 24.60 K
Shares Sold 0.00 0.00

Insider Activity

Transaction Date Insider/Title Transaction Type Market Value Shares Average Price Current Holdings

LATEST NEWS

Recent Articles from TheStreet

Walmart Lead

Walmart CFO Brett Biggs Leaving After 22 Years

Walmart says Biggs stay on as CFO until a successor is named and will remain as an associate until he leaves in January 2023.

Ready to Trade Bristol-Myers Squibb, Bank of America, CSX? Here's What to Know

Bristol Myers Stock Falls Despite Positive News on Psoriasis Drug

Bristol Myers shares fall after the FDA accepts its psoriasis-treating deucravacitinib drug application, and European regulators also validate its application.

Is Best Buy Stock an Investor Best Buy After Earnings Beat? -- The Charts Speak

Best Buy, Big-Box Store Inventory Strong, Roku Demand High: Wedbush

Wedbush finds no shortage of in-store inventory for consumer electronics. And it says Roku products are in strong demand.

Can Twitter's Jack Dorsey Keep the Good Times Rolling?

Twitter Stock Leaps Amid Report CEO Jack Dorsey Will Step Down

Twitter co-founder Jack Dorsey is set to step-down as CEO of the microblogging website, CNBC reported Monday.

Stock Market Lead

Wells Fargo Bullish on Quality Stocks, Despite Omicron

'We do not recommend de-risking into weakness,' Chris Harvey, head of equity strategy for Wells, writes in a commentary.

Amazon's Potential Delivery Service Not a Reason to Sell FedEx, UPS: Jim Cramer

Amazon Invests in Bypassing Retail Supply Chain Issues

Amazon has built more than 450 new facilities nationwide in recent months in order to beat supply chain issues.

Bitcoin Lead

Cryptocurrency Price Check: Bitcoin Bounces Back After Omicron Scare

Bitcoin 'is leading the market back from the depths of despair,' a cryptocurrency analyst says.

Moderna vaccine Lead

Premarket Movers Monday: Moderna, Zoom Video

Stock futures rose Monday amid travel curbs tied to the omicron Covid variant.

Pfizer Pill Lead

Pfizer Stock Jumps On Plan To Boost Covid Pill Production In Fight Against Omicron Variant

Pfizer CEO Albert Bourla confirmed the drugmaker's plans to boost production of its Paxlovid antivrical treatment in the first against the spread of the new Omicron variant.

Lufax is set to make the biggest splash on the NYSE by a Chinese company since e-commerce giant Alibaba's IPO in 2014. Photo: Reuters

Dow Futures Rebound As Omicron Fears Ease; Pfizer, Moderna, Oil Move Higher- Stock Market Today

Wall Street looks to rebound from the worst Black Friday session on record Monday as investors continue to track developments in the spread of the newly-discovered Omicron variant.